ORPHA:188
Systemic capillary leak syndrome
Also known as: Capillary hyperpermeability syndrome · Capillary leak syndrome · Clarkson disease · Idiopathic capillary leak syndrome · SCLS
Publications
4,600
Trials
0
Interventional, condition-specific
Researchers
947
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
Systemic capillary leak syndrome (SCLS) is a severe systemic disease due to increased capillary permeability, characterized by episodes of hypotension, edema and hypovolemia.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0001956
- MeSH:D019559
- UMLS:C0343084
- NCIT:C62578
Additional Mondo synonyms (8)
AVLS · CLS · Systemic Capillary Leak Syndrome · acute vascular leak syndrome · capillary hyperpermeability syndrome · capillary leak syndrome · idiopathic capillary leak syndrome · systemic capillary leak syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
4,600 matched papers (2,829 in last 10 years) Source
- Phenotype characterisedPresent
23 HPO annotations (e.g. Pancreatitis; Pedal edema; Weight loss) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
23
Associated phenotypes · MONDO:0001956
- Pancreatitis
- Pedal edema
- Weight loss
- Diarrhea
- Fatigue
Showing 5 of 23 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
16 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Aminophylline · therapeutic
- Curcumin · therapeutic
- Dexamethasone · therapeutic
- Glucocorticoids · therapeutic
- Hydroxyethyl Starch Derivatives · therapeutic
- Terbutaline · therapeutic
- VAD combination · therapeutic
- Acitretin · marker/mechanism
- aldesleukin · marker/mechanism
- Bortezomib · marker/mechanism
- Cisplatin · marker/mechanism
- Clofarabine · marker/mechanism
Literature
Is anyone studying this?
4,600
4,600 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
4,600 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
2,829 in the last 10 years · low confidence
Phrase hits: 4,600 · MeSH hits: 0
Who's working on it?
947
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Druey KM20 papers · 2024
Laboratory of Allergic Diseases, NIAID/NIH, Bethesda, MD, USA.
Papers in Europe PMC - 02Xie Z11 papers · 2019
Laboratory of Allergic Diseases, NIAID/NIH, Bethesda, MD, USA.
Papers in Europe PMC - 03Amoura Z8 papers · 2022
Service de médecine interne 2, CHU La Pitié-Salpêtrière, APHP, Université Paris 6, France. Electronic address: zahir.amoura@aphp.fr.
Papers in Europe PMC - 04Parikh SM8 papers · 2024
Department of Medicine, Division of Nephrology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Papers in Europe PMC - 05Pineton de Chambrun M8 papers · 2022
1Service de Médecine Interne 2, Centre Hospitalier Universitaire (CHU) La Pitié-Salpêtrière, Université Paris 6, APHP, Paris, France.2Service de Réanimation Médicale, CHU La Pitié-Salpêtrière, Université Paris 6, APHP, Paris, France.3Service de Réanimation Médicale, CHU d'Angers, Angers, France.4Service de Médecine Interne, CH Bretagne Atlantique, Vannes, France.5Service de Réanimation Médicale, CHU Edouard-Herriot, Lyon, France.6Service de Réanimation, CHU Lyon-Sud, Pierre-Bénite, France.7Service de Réanimation Polyvalente, CH Pierre Oudot, Bourgoin Jallieu, France.8Service de Réanimation Médicale, CHRU Lille, Lille, France.9Service de Réanimation Médicale, CHU Bichat, APHP, Paris, France.10Service de Réanimation Polyvalente, Hôpital Delafontaine, Saint-Denis, France.11Service de Réanimation Polyvalente, CH André-Mignot, Le Chesnay, France.12Service de Réanimation Médicale, CHU Hôtel-Dieu, Nantes, France.13Service de Réanimation Médicale, CHU Henri-Mondor, APHP, Créteil, France.14Service de Pneumologie et de Réanimation Médicale, CHU La Pitié-Salpêtrière, APHP, Paris, France.15Service de Réanimation Chirurgicale, CHU Lyon-Est, Hôpital Louis-Pradel, Bron, France.16Service de Réanimation Médicale, Hôpital Gabriel-Montpied, CHU Clermont-Ferrand, Clermont-Ferrand, France.17Service de Réanimation Polyvalente, CH Notre-Dame de la Miséricorde, Ajaccio, France.18Service de Réanimation Médicale, CHU Ambroise-Paré, APHP, Boulogne-Billancourt, France.19Service de Réanimation Médicale, CHU Grenoble, Grenoble, France.20Service de Réanimation Médicale, CHU Saint-Louis, APHP, Paris, France.21Service de Réanimation, Hôpital du Valais-Institut Central, Sion, Switzerland.22Service de Réanimation, Hôpital d'Instruction des Armées Desgenettes, Lyon, France.23Service de Réanimation Polyvalente, CH Foch, Suresnes, France.24Service de Réanimation, CH Dax, Dax, France.25Service de Réanimation Polyvalente, CH Bretagne Atlantique, Vannes, France.26Service de Réanimation Médicale, CHU Cochin, APHP, Paris, France.27Service de Réanimation Adulte, CHU Necker-Enfants Malades, APHP, Paris, France.
Papers in Europe PMC - 06Colombo R7 papers · 2025
Division of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.
Papers in Europe PMC - 07Wu MA7 papers · 2025
Division of Internal Medicine, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Via G.B. Grassi 74, 20157, Milan, Italy. maddalena.wu@unimi.it.
Papers in Europe PMC - 08Chan EC6 papers · 2024
Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Md.
Papers in Europe PMC - 09Long LM6 papers · 2019
National Institute of Allergy and Infectious Diseases, National Institutes of Health, 50 South Drive Room 4154, Bethesda, MD, 20892-8305, USA.
Papers in Europe PMC - 10Luyt CE6 papers · 2022
Service de Réanimation Médicale, Institut de Cardiologie, Hôpital La Pitié-Salpêtrière, Sorbonne Université, Assistance Publique Hôpitaux de Paris, Paris, France.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 4 observational studies did — shown below because natural-history and cohort work can be an important step toward a trial.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Observational and natural-history studies
4 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 16 · after dedupe 16 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 16 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (16)
- ctis·2024-513141-37-00·Expired·Immunotherapy with dinutuximab beta in combination with chemotherapy for the treatment of patients with primary neuroblastoma refractory to standard therapy and with relapsed or progressive disease.
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN72157798·Recruiting·Developing a vaccine against Bundibugyo ebolavirus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12537955·Not yet recruiting·Comparing a new combination of medicines to the usual intensive chemotherapy treatment given to participants who have been recently diagnosed with acute myeloid leukaemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN90309905·Recruiting·ViTaL02: A study of a new vaccine against Lassa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN62461807·No longer recruiting·A study of a vaccine against Nipah Virus in adults aged 18 to 55 years in Bangladesh
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16084957·No longer recruiting·VITAL01: A study of a new vaccine against Lassa fever in adults aged 18-55 years
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11688703·No longer recruiting·Examining lymph node cells to assess how age affects immune responses
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN97679658·No longer recruiting·A study of a new vaccine against Marburg virus in adults aged 18–55 years
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN87634044·No longer recruiting·A study of a new vaccine against Nipah virus in adults aged 18 to 55 years
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12928349·No longer recruiting·Lymph node flu and COVID-19 vaccine responses in younger or older adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12351734·No longer recruiting·A study of a new vaccine against Crimean-Congo Haemorrhagic Fever (a life-threatening tick-borne viral disease)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17936606·No longer recruiting·A study of a new vaccine against the MERS virus in adults aged 50 to 70 years
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN52566874·No longer recruiting·Activated protein C versus placebo in the treatment of INFlammatory or infectious Acute Lung Injury/acute respiratory distress syndrome (INFALI): a pathophysiological study on pulmonary microvascular permeability, apoptosis, inflammation and coagulation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN53507177·No longer recruiting·Clinical trial studying antibody treatment combined with COVID-19 vaccination in immunocompromised individuals
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65113000·No longer recruiting·What is the impact of a modified Roux-en-Y-gastric bypass operation on people with type 2 diabetes mellitus?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN19924570·No longer recruiting·The use of high frequency oscillator ventilation (HFOV) in paediatric acute respiratory distress syndrome (ARDS) with open lung technique
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Systemic capillary leak syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Systemic capillary leak syndrome" OR "Capillary hyperpermeability syndrome" OR "Capillary leak syndrome" OR "Clarkson disease" OR "Idiopathic capillary leak syndrome" OR "acute vascular leak syndrome")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Systemic capillary leak syndrome" OR "Capillary hyperpermeability syndrome" OR "Capillary leak syndrome" OR "Clarkson disease" OR "Idiopathic capillary leak syndrome" OR "acute vascular leak syndrome"
Study-type breakdown: 0 interventional · 4 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: SCLS; AVLS; CLS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 3 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (4600) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-26T12:49:57.302Z
